Business & Finance
GBT achieves higher adjusted net income of BRL36.9m for Q4 2017
20 March 2018 -

Biopharmaceutical company Biotoscana Investments SA (GBT) (B3:GBIO33) stated on Monday that its adjusted net income was BRL36.9m for the fourth quarter 2017.

This marks a growth of 6.9% in constant currency when compared with the adjusted net income in the same period of the year before.

Gross revenues of BRL271.6m was generated for the fourth quarter 2017 , up 14% in constant currency against the fourth quarter 2016. In the fourth quarter 2017, the net revenues rose by 17.8% to BRL244.4m in constant currency against the fourth quarter 2016.

Gross profit of BRL140.3m was recorded for the fourth quarter 2017, a rise of 14.4% in constant currency versus the fourth quarter in the previous year.

Adjusted EBITDA of BRL73.2m was reported in the fourth quarter 2017, an improvement of 5.5% in constant currency over the fourth quarter 2016.

(USD1=BRL3.28584)

Login
Username:

Password: